首頁 › 非小細胞肺癌 › 科羅拉多 › Centennial
Centennial, CO 的 非小細胞肺癌 臨床試驗
15 項針對 非小細胞肺癌 的研究正在 Centennial（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
招募中1/2 期
- Rocky Mountain Cancer Centers - Lone Tree /ID# 272603, Lone Tree · 距離 2 英里
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Kaiser Permanente-Lone Tree, Lone Tree · 距離 2 英里
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
招募中2 期
- AdventHealth Parker, Parker · 距離 7 英里
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
招募中3 期
- Kaiser Permanente-Lone Tree, Lone Tree · 距離 2 英里
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
招募中3 期
- Rocky Mountain Cancer Centers LLP, Centennial
- Rocky Mountain Cancer Centers LLP, Lone Tree · 距離 2 英里
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
招募中2 期
- Rocky Mountain Cancer Centers, Lone Tree · 距離 2 英里
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
招募中1/2 期
- Rocky Mountain Cancer Centers,LLP, Lone Tree · 距離 2 英里
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
招募中3 期
- Clinical Study Site, Lone Tree · 距離 2 英里
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
招募中2/3 期
- Local Institution - 007-872-L, Centennial
- USOR - Rocky Mountain Cancer Centers - Lone Tree, Lone Tree · 距離 2 英里
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
招募中1/2 期
- Rocky Mountain Cancer Centers, Lone Tree · 距離 2 英里
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
招募中3 期
- USO - Rocky Mountain Cancer Centers, Lone Tree · 距離 2 英里
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
招募中1 期
- Rocky Mountain Cancer Centers, LLP - Oncology, Lone Tree · 距離 2 英里
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
招募中2 期
- UCHealth Lone Tree Health Center, Lone Tree · 距離 2 英里
Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.
招募中觀察性研究
- Lone Tree Medical Center, Lone Tree · 距離 2 英里
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
招募中觀察性研究
- Rocky Mountain Cancer Centers - Centennial, Centennial
- Kaiser Permanente-Lone Tree, Lone Tree · 距離 2 英里
- Rocky Mountain Cancer Centers-Sky Ridge, Lone Tree · 距離 2 英里
其他城市的 非小細胞肺癌 試驗
- Houston, TX145 項研究
- New York City, NY121 項研究
- Arlington, VA104 項研究
- Nashville, TN97 項研究
- Boston, MA90 項研究
- Los Angeles, CA87 項研究
- St. Louis, MO73 項研究
- Chicago, IL61 項研究
- Baltimore, MD60 項研究
- San Antonio, TX59 項研究
- Columbus, OH57 項研究
- Washington, DC55 項研究
Centennial 的其他研究
- 大腸直腸癌9 項研究
- 乳癌9 項研究
- 肺癌8 項研究
- 膀胱癌7 項研究
- 前列腺癌7 項研究
- 腎臟癌（腎細胞癌）6 項研究
- 胃癌5 項研究
- 轉移性癌症5 項研究
- 食道癌4 項研究
- 胰臟癌4 項研究
- 結腸癌4 項研究
- 腦下垂體性侏儒症3 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。